S1468 Semaglutide and Tirzepatide Have the Most Clinical Benefit Compared to Most Weight Loss Medications in Inflammatory Bowel Disease
Year: 2025
Type: conference-abstract
Authors: Himaben Gohil, Xavier Zonna, Lan Nguyen, Randy Cheung, Erin Ly
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4417165294
Cites:
Cited by:
Related to: